Virginia bills · 2026 Regular Session
Virginia HB 1025
Access to investigational drugs, etc.; patient with severely debilitating condition.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Wendell S. Walker (Republican)
Cosponsors (1)
- Wren M. Williams (Republican)
Summary
Official abstract published by the Virginia legislature· SUMMARY AS INTRODUCED
Access to investigational drugs, biological products, and devices; patient with severely debilitating condition. Allows a patient who has a severely debilitating condition, defined in the bill as a disease or condition that causes major irreversible morbidity, to access investigational drugs, biological products, and devices when certain criteria are met. Under current law, only a patient who has a terminal condition may access such drugs, products, and devices.
Text versions
Roll-call votes
State vote data last updated Oct 15, 2026, 8:04 PM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Feb 10, 2026 House | Subcommittee recommends laying on the table | pass | Set your home in Virginia to see |
Actions
- Feb 18, 2026 · House
Left in Committee Health and Human Services - Feb 10, 2026 · House
Subcommittee recommends laying on the table (7-Y 1-N) - Feb 5, 2026 · House
Fiscal Impact Statement from Department of Planning and Budget (HB1025) - Jan 23, 2026 · House
Assigned sub: Health - Jan 14, 2026 · House
Referred to Committee on Health and Human Services - Jan 14, 2026 · House
Prefiled and ordered printed; Offered 01-14-2026 26102452D